Methyl jasmonate induces apoptosis through induction of Bax/Bcl-X sand activation of caspase-3 via ROS production in A549 cells

Oncology Reports

Volumn 12, Issue 6, 2004, Pages 1233-1238

  Kim, Ji Hye ^a   Lee, Su Yeon ^a   Oh, Su Young ^a   Han, Song Iy ^a   Park, Hye Gyeong ^a   Yoo, Mi Ae ^a   Kang, Ho Sung ^a  

^a Pusan National University   (South Korea)

Author keywords

Apoptosis; Bax Bcl Xs; Caspase 3; Methyl jasmonate; Reactive oxygen species

Indexed keywords

ACETIC ACID DERIVATIVE; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CYCLOPENTANE DERIVATIVE; JASMONIC ACID METHYL ESTER; PHYTOHORMONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CONFOCAL MICROSCOPY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE; WESTERN BLOTTING;

ACETIC ACIDS; ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE, TUMOR; CYCLOPENTANES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; HUMANS; MEMBRANE POTENTIALS; MICROSCOPY, CONFOCAL; MITOCHONDRIA; PLANT GROWTH REGULATORS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 16644392664     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Meier P, Finch A and Evan G: Apoptosis in development. Nature 407: 796-801, 2000.
2. Green DR: Apoptotic pathways: paper wraps stone blunts scissors. Cell 102: 1-4, 2000.
3. Jonstone RW: Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164, 2002.
4. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ and Williams LT: Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278: 294-298, 1997. (Pubitemid 27450877)
5. Martinou JC and Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 1: 63-67, 2001.
6. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
7. Atan G, James MM and Stanley JK: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
8. Cory S and Adams JM: The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002. (Pubitemid 37328916)
9. Christophe F, Bernard M and Jean-Luc V: Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141, 2002.
10. 2 in cardiac myocytes. J Biol Chem 278: 25542-25547, 2003.
11. Kunkel BN and Brooks DM: Cross talk between signaling pathways in pathogen defense. Curr Opin Plant Biol 5: 325-331, 2002. (Pubitemid 34695970)
12. Turner JG, Ellis C and Devoto A: The Jasmonate signal pathway. Plant Cell 14: 153-164, 2002.
13. Liechti R and Farmer EE: The jasmonate pathway. Science 296: 1649-1650, 2002. (Pubitemid 34579154)
14. Fingrut O and Flescher E: Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 16: 608-616, 2002. (Pubitemid 34449741)
15. Lee EJ, Park HG and Kang HS: Sodium salicylate induces apoptosis in HCT116 colorectal cancer cells through activation of p38MAPK. Int J Oncol 23: 503-508, 2003.
16. Frisch SM and Screaton RA: Anoikis mechanisms. Curr Opin Cell Biol 5: 555-562, 2001. (Pubitemid 32817013)
17. Sharpless NE and DePinho RA: p53: good cop/bad cop. Cell 110: 9-12, 2002. (Pubitemid 34874601)
18. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442, 2003.
19. S and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J Neurochem 4: 842-852, 2002.
20. Mandal M, Olson DJ, Sharma T, Vadlamudi RK and Kumar R: Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 1: 71-78, 2001. (Pubitemid 32061870)
21. Chen WJ and Lin JK: Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins. J Biol Chem 279: 13496-13505, 2004.
22. Li B and Dou QP: Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression. Proc Natl Acad Sci USA 97: 3850-3855, 2000. (Pubitemid 30226050)
23. Simizu S, Umezawa K, Takada M, Arber N and Imoto M: Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells. Exp Cell Res 238: 197-203, 1998. (Pubitemid 28366142)
24. Brazil DP and Hemmings BA: Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664, 2001. (Pubitemid 33042488)
25. Pap M and Cooper GM: Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273: 19929-19932, 1998. (Pubitemid 28377539)
26. Rytomaa M, Lehmann K and Downward J: Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 39: 4461-4468, 2000.
27. Yamaguchi H and Wang HG: The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20: 7779-7786, 2001. (Pubitemid 33121951)
28. Nicholson KM and Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395, 2002. (Pubitemid 34214843)
29. Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997, 2001. (Pubitemid 32720961)
30. Aspenstrom P: Effectors for the Rho GTPases. Curr Opin Cell Biol 11: 95-102, 1999.
31. Bar-sagi D and Hall A: Ras and Rho GTPases: A Family Reunion. Cell 103: 227-238, 2000.
32. Kamata H and Hirata H: Redox regulation of cellular signalling. Cell Signal 11: 1-14, 1999. (Pubitemid 28546635)
33. Benhar M, Dalyot I, Engelberg D and Levitzki A: Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21: 6913-6926, 2001. (Pubitemid 32911252)
34. Tegeder I, Pfeilschifter J and Geisslinger G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15: 2057-2072, 2001. (Pubitemid 32927924)
35. Elder DJ, Hague A, Hicks DJ and Paraskeva C: Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res 56: 2273-2276, 1996.
36. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY and Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-lerminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94: 2869-2773, 1997.
37. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G and Gil J: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92: 1406-1414, 1999.